Overview

PK/PD Modeling of Magnesium in the Mother and Neonate

Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
0
Participant gender:
All
Summary
Determine significant correlations between maternal serum magnesium levels, and maternal and neonatal outcomes.
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Stanford University
Treatments:
Magnesium Sulfate
Criteria
Inclusion Criteria:

- Pregnant women ages 18-45 years

- Magnesium sulfate exposure for preeclampsia, tocolysis, or neuroprotection

- Neonates (male or female) born at 24-42 weeks gestation